• <tr id="nbfgq"></tr>
  • BRL Medicine's new generation of universal CAR-T therapy has been approved by domestic IND

    MORE

    BRL Medicine World's first non viral PD1 fixed-point integration CAR-T product

    MORE

    World’s first clinical trial of non-viral PD1 specific targeted CART therapy achieves great breakthroughs

    MORE

    Lead the world! BRL Medicine's new generation of Quikin CAR-T research results published in Nature

    MORE

    BRL Medicine published in Nature Medicine that BRL-101 gene therapy for children with thalassemia has been free of transfusion dependence for more than 2 years

    MORE

    About BRL Medicine

    At BRL Medicine Inc., we aim to become the world's leading Cellular & Gene pharmaceutical company in the era of new commercial civilization, with the mission of?"Through innovation led by gene editing, develop breakthrough human therapeutics and benefit the whole world". With its independent R&D center and the "Shanghai Research Center for Gene Editing and Cell Therapy", jointly established by?BRL Medicine and university,?BRL Medicine?has obtained more than 100 patent achievements, and initiated 5 Investigator-Initiated clinical Trials (IIT) in 8 leading hospitals in China, with many pipeline projects have entered into IND application stage.?

    Learn More

    Gene Therapy

    The world's first CRISPR gene editing
    treatment of β0/β0 type thalassemia is successful

    LEARN MORE

    Cell Therapy

    World's first clinical trial of non-viral PD1
    specific targeted CART therapy achieves great breakthroughs

    LEARN MORE

    Product Pipeline

    Subscribe:Submit
    Back to top
    亚洲欧美日韩国产精品一区二区_在线视频免费人妻_一本久道综合在线无码人妻_国产无码高清在线观看